Advertisement

Journal of Cancer Survivorship

, Volume 10, Issue 5, pp 850–864 | Cite as

Complementary and alternative medicine use among US cancer survivors

  • Gabriella M. John
  • Dawn L. Hershman
  • Laura Falci
  • Zaixing Shi
  • Wei-Yann Tsai
  • Heather GreenleeEmail author
Article

Abstract

Purpose

US cancer survivors commonly use vitamins/minerals and complementary and alternative medicine (CAM). We compare use of vitamins/minerals and CAM between adult cancer survivors and cancer-free adults and estimate annual out-of-pocket expenses.

Methods

Data on self-reported vitamin/mineral and CAM use in the past 12 months from the cross-sectional 2012 US National Health Interview Survey were used to estimate prevalence of use and out-of-pocket expenditures. The cohort included adults with (n = 2977) and without (n = 30,551) a self-reported cancer diagnosis.

Results

Approximately 79 % of cancer survivors and 68 % of cancer-free adults reported using ≥1 vitamins/minerals and/or CAM modality in the past year. Compared to cancer-free adults, cancer survivors were more likely to report use of vitamin/minerals (75 vs. 61 %, P < 0.001), non-vitamin/mineral natural products (24 vs. 19 %, P < 0.001), manipulative and body-based therapies (19 vs. 17 %, P = 0.03), and alternative medical systems (5 vs. 4 %, P = 0.04). Adult cancer survivors and cancer-free adults spent an annual estimated $6.7 billion and $52 billion out-of-pocket, respectively, on vitamins/minerals and CAM. Survivors spent 60 % of the total on vitamins/minerals ($4 billion), 18 % ($1.2 billion) on non-vitamin/mineral natural products, and 7 % ($0.5 billion) on massage.

Conclusions

Compared with cancer-free adults, a higher proportion of cancer survivors report vitamin/mineral and CAM use. Cancer survivors, who accounted for 6.9 % of the total population, accrued more than 11.4 % of the annual out-of-pocket costs on vitamins/minerals and CAM spent by US adults.

Implications for Cancer Survivors

Given the high use of vitamins/minerals and CAM in cancer survivors, studies are needed to analyze health outcomes and the cost/benefit ratio of such use.

Keywords

Vitamins Complementary therapies Complementary medicine Healthcare costs Cancer 

Notes

Acknowledgments

The authors thank Richard Nahin, Ph.D. at the National Center for Complementary and Integrative Health for his insightful comments and helpful suggestions on the data analysis and interpretation. Funding was provided by National Cancer Institute K23CA141052 (to Heather Greenlee).

Compliance with ethical standards

Conflict of interest

None

Disclosures

An earlier version of this analysis was presented at the 2014 International Research Congress on Integrative Medicine and Health in Miami, Florida.

Supplementary material

11764_2016_530_MOESM1_ESM.docx (34 kb)
ESM 1 (DOCX 34 kb)
11764_2016_530_MOESM2_ESM.docx (19 kb)
ESM 2 (DOCX 18 kb)
11764_2016_530_MOESM3_ESM.docx (20 kb)
ESM 3 (DOCX 20 kb)

References

  1. 1.
    Nahin RL, Barnes PM, Stussman BJ, Bloom B. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. Natl Health Stat Report. 2009;(18):1–14Google Scholar
  2. 2.
    Mao JJ, Palmer CS, Healy KE, Desai K, Amsterdam J. Complementary and alternative medicine use among cancer survivors: a population-based study. J Cancer Surv. 2011;5(1):8–17. doi: 10.1007/s11764-010-0153-7.CrossRefGoogle Scholar
  3. 3.
    Velicer CM, Ulrich CM. Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. J Clin Oncol. 2008;26(4):665–73. doi: 10.1200/JCO.2007.13.5905.CrossRefPubMedGoogle Scholar
  4. 4.
    National Center for Complementary and Integrative Health. Get the facts: cancer and complementary health approaches. https://nccih.nih.gov/sites/nccam.nih.gov/files/Get_The_Facts_Cancer_and_CHA_07-15-2014.pdf. Accessed 6 Dec 2015.
  5. 5.
    Mao JJ, Farrar JT, Xie SX, Bowman MA, Armstrong K. Use of complementary and alternative medicine and prayer among a national sample of cancer survivors compared to other populations without cancer. Complement Ther Med. 2007;15(1):21–9. doi: 10.1016/j.ctim.2006.07.006.CrossRefPubMedGoogle Scholar
  6. 6.
    Patterson RE, Neuhouser ML, Hedderson MM, Schwartz SM, Standish LJ, Bowen DJ, et al. Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med. 2002;8(4):477–85. doi: 10.1089/107555302760253676.CrossRefPubMedGoogle Scholar
  7. 7.
    Greenlee H, White E, Patterson RE, Kristal AR. Supplement use among cancer survivors in the Vitamins and Lifestyle (VITAL) study cohort. J Altern Complement Med. 2004;10(4):660–6. doi: 10.1089/acm.2004.10.660.CrossRefPubMedGoogle Scholar
  8. 8.
    Stussman BJ, Bethell CD, Gray C, Nahin RL. Development of the adult and child complementary medicine questionnaires fielded on the National Health Interview Survey. BMC Complement Altern Med. 2013;13:328. doi: 10.1186/1472-6882-13-328.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Centers for Disease Control and Prevention. About the National Health Interview Survey. 2012. http://www.cdc.gov/nchs/nhis/about_nhis.htm. Accessed 6 Dec 2015.
  10. 10.
    Willson S, Stussman B, Maitland A, Nahin RL. Role of self-concept in answering survey questions on complementary and alternative medicine: challenges to and strategies for improving data quality. J Altern Complement Med. 2009;15(12):1319–25.CrossRefPubMedGoogle Scholar
  11. 11.
    Goodman RA, Posner SF, Huang ES, Parekh AK, Koh HK. Defining and measuring chronic conditions: imperatives for research, policy, program, and practice. Prev Chronic Dis. 2013;10, E66. doi: 10.5888/pcd10.120239.PubMedPubMedCentralGoogle Scholar
  12. 12.
    Adams PF KW, Martinez ME. Summary health statistics for the U.S. population: National Health Interview Survey, 2012. National Center for Health Statistics. Vital Health Stat 10(259). 2013.Google Scholar
  13. 13.
    Lumley T. Analysis of complex survey samples. J Stat Softw. 2004;9(1):1–19.Google Scholar
  14. 14.
    Therneau TM, Lumley TR. Survival analysis: [computer program]. CRAN (2014).Google Scholar
  15. 15.
    Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Inst. 2011;103(2):117–28. doi: 10.1093/jnci/djq495.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Davis MA, Martin BI, Coulter ID, Weeks WB. US spending on complementary and alternative medicine during 2002–08 plateaued, suggesting role in reformed health system. Health Aff (Millwood). 2013;32(1):45–52. doi: 10.1377/hlthaff.2011.0321.CrossRefGoogle Scholar
  17. 17.
    Greenlee H, Kwan ML, Ergas IJ, Strizich G, Roh JM, Wilson AT, et al. Changes in vitamin and mineral supplement use after breast cancer diagnosis in the pathways study: a prospective cohort study. BMC Cancer. 2014;14(1):382.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Link AR, Gammon MD, Jacobson JS, Abrahamson P, Bradshaw PT, Terry MB, et al. Use of self-care and practitioner-based forms of complementary and alternative medicine before and after a diagnosis of breast cancer. Evid Based Complement Altern Med. 2013;2013:16. doi: 10.1155/2013/301549.CrossRefGoogle Scholar
  19. 19.
    Greenlee H, Kwan ML, Ergas IJ, Sherman KJ, Krathwohl SE, Bonnell C, et al. Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways Study. Breast Cancer Res Treat. 2009;117(3):653–65. doi: 10.1007/s10549-009-0315-3.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Miller MF, Bellizzi KM, Sufian M, Ambs AH, Goldstein MS, Ballard-Barbash R. Dietary supplement use in individuals living with cancer and other chronic conditions: a population-based study. J Am Diet Assoc. 2008;108(3):483–94. doi: 10.1016/j.jada.2007.12.005.CrossRefPubMedGoogle Scholar
  21. 21.
    Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the united states, 1990–1997: Results of a follow-up national survey. JAMA. 1998;280(18):1569–75. doi: 10.1001/jama.280.18.1569.CrossRefPubMedGoogle Scholar
  22. 22.
    Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States—prevalence, costs, and patterns of use. N Engl J Med. 1993;328(4):246–52. doi: 10.1056/NEJM199301283280406.CrossRefPubMedGoogle Scholar
  23. 23.
    Sohl SJ, Weaver KE, Birdee G, Kent EE, Danhauer SC, Hamilton AS. Characteristics associated with the use of complementary health approaches among long-term cancer survivors. Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 2014;22(4):927–36.Google Scholar
  24. 24.
    National Center for Complementary and Alternative Medicine. Complementary, alternative, or integrative health: what’s in a name? National Center for Complementary and Alternative Medicine, Bethesda, Maryland. (2013) http://nccam.nih.gov/health/whatiscam. Accessed 6 Dec 2015.
  25. 25.
    Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Rep. 2008;10(12):1–23.Google Scholar
  26. 26.
    Deng GE, Frenkel M, Cohen L, Cassileth BR, Abrams DI, Capodice JL, et al. Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. J Soc Integr Oncol. 2009;7(3):85–120.PubMedGoogle Scholar
  27. 27.
    Deng GE, Rausch SM, Jones LW, Gulati A, Kumar NB, Greenlee H, et al. Complementary therapies and integrative medicine in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e420S–36S. doi: 10.1378/chest.12-2364.CrossRefPubMedGoogle Scholar
  28. 28.
    Greenlee H, Balneaves LG, Carlson LE, Cohen M. Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer. J Natl Cancer Inst Monogr. 2014;2014(50):346–58. doi: 10.1093/jncimonographs/lgu041.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Luc L, Baumgart C, Weiss E, Georger L, Ambrosone CB, Zirpoli G, et al. Dietary supplement use among participants of a databank and biorepository at a comprehensive cancer centre. Public Health Nutr. 2015;18(5):916–26. doi: 10.1017/s1368980014001062.CrossRefPubMedGoogle Scholar
  30. 30.
    Lafferty WE, Tyree PT, Devlin SM, Andersen MR, Diehr PK. Complementary and alternative medicine provider use and expenditures by cancer treatment phase. Am J Manag Care. 2008;14(5):326–34.PubMedPubMedCentralGoogle Scholar
  31. 31.
    Ubel PA, Abernethy AP, Zafar SY. Full disclosure—out-of-pocket costs as side effects. N Engl J Med. 2013;369(16):1484–6. doi: 10.1056/NEJMp1306826.CrossRefPubMedGoogle Scholar
  32. 32.
    Guy Jr GP, Ekwueme DU, Yabroff KR, Dowling EC, Li C, Rodriguez JL, et al. Economic burden of cancer survivorship among adults in the United States. J Clin Oncol. 2013;31(30):3749–57. doi: 10.1200/jco.2013.49.1241.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Armstrong T, Cohen MZ, Hess KR, Manning R, Lee EL, Tamayo G, et al. Complementary and alternative medicine use and quality of life in patients with primary brain tumors. J Pain Symptom Manag. 2006;32(2):148–54. doi: 10.1016/j.jpainsymman.2006.02.015.CrossRefGoogle Scholar
  34. 34.
    Wyatt G, Sikorskii A, Wills CE, Su H. Complementary and alternative medicine use, spending, and quality of life in early stage breast cancer. Nurs Res. 2010;59(1):58–66. doi: 10.1097/NNR.0b013e3181c3bd26.CrossRefPubMedGoogle Scholar
  35. 35.
    Howlader N, A.M. N, Krapcho M, Garshell J, Miller D, Altekruse SF et al. SEER Cancer Statistics Review, 1975–2011. National Cancer Institute, Bethesda, MD. 2014. http://seer.cancer.gov/archive/csr/1975_2011/. Accessed 6 Dec 2015
  36. 36.
    Briggs A, Gray A. The distribution of health care costs and their statistical analysis for economic evaluation. J Health Serv Res Policy. 1998;3(4):233–45.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Gabriella M. John
    • 1
  • Dawn L. Hershman
    • 1
    • 2
    • 3
  • Laura Falci
    • 1
  • Zaixing Shi
    • 1
  • Wei-Yann Tsai
    • 4
    • 3
  • Heather Greenlee
    • 1
    • 3
    Email author
  1. 1.Department of Epidemiology, Mailman School of Public HealthColumbia UniversityNew YorkUSA
  2. 2.Department of Medicine, College of Physicians and SurgeonsColumbia UniversityNew YorkUSA
  3. 3.Herbert Irving Comprehensive Cancer CenterColumbia University Medical CenterNew YorkUSA
  4. 4.Department of Biostatistics, Mailman School of Public HealthColumbia UniversityNew YorkUSA

Personalised recommendations